Metropolitan Life Insurance Company (MetLife)’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,592
| Closed | -$222K | – | 1616 |
|
|
2024
Q1 | $222K | Sell |
18,592
-1,894
| -9% | -$21K | 0.01% | 674 |
|
|
2023
Q4 | $221K | Hold |
20,486
| – | – | 0.01% | 687 |
|
|
2023
Q3 | $284K | Buy |
20,486
+8,722
| +74% | +$128K | 0.01% | 564 |
|
|
2023
Q2 | $141K | Buy |
11,764
+339
| +3% | +$3.83K | 0.01% | 842 |
|
|
2023
Q1 | $134K | Sell |
11,425
-1,824
| -14% | -$26.6K | 0.01% | 852 |
|
|
2022
Q4 | $223K | Buy |
13,249
+309
| +2% | +$5.1K | 0.01% | 670 |
|
|
2022
Q3 | $151K | Hold |
12,940
| – | – | 0.01% | 794 |
|
|
2022
Q2 | $204K | Buy |
12,940
+946
| +8% | +$15.9K | 0.01% | 683 |
|
|
2022
Q1 | $186K | Sell |
11,994
-30,039
| -71% | -$379K | 0.01% | 851 |
|
|
2021
Q4 | $355K | Sell |
42,033
-9,034
| -18% | -$77.8K | ﹤0.01% | 1639 |
|
|
2021
Q3 | $460K | Sell |
51,067
-1,908
| -4% | -$15.4K | 0.01% | 1520 |
|
|
2021
Q2 | $527K | Buy |
52,975
+3,192
| +6% | +$27K | 0.01% | 1489 |
|
|
2021
Q1 | $355K | Buy |
49,783
+1,348
| +3% | +$9.5K | 0.01% | 1634 |
|
|
2020
Q4 | $255K | Sell |
48,435
-10,330
| -18% | -$40.6K | ﹤0.01% | 1777 |
|
|
2020
Q3 | $167K | Hold |
58,765
| – | – | ﹤0.01% | 1896 |
|
|
2020
Q2 | $204K | Buy |
58,765
+7,096
| +14% | +$24.5K | ﹤0.01% | 1783 |
|
|
2020
Q1 | $121K | Sell |
51,669
-2,868
| -5% | -$18.6K | ﹤0.01% | 1909 |
|
|
2019
Q4 | $573K | Sell |
54,537
-1,918
| -3% | -$17.4K | 0.01% | 1238 |
|
|
2019
Q3 | $483K | Sell |
56,455
-3,306
| -6% | -$32.4K | 0.01% | 1319 |
|
|
2019
Q2 | $688K | Sell |
59,761
-1,323
| -2% | -$17K | 0.01% | 1110 |
|
|
2019
Q1 | $856K | Sell |
61,084
-1,080
| -2% | -$14.2K | 0.02% | 962 |
|
|
2018
Q4 | $643K | Sell |
62,164
-595
| -0.9% | -$8.77K | 0.01% | 1058 |
|
|
2018
Q3 | $1.07M | Sell |
62,759
-106,125
| -63% | -$1.82M | 0.02% | 897 |
|
|
2018
Q2 | $3.04M | Buy |
168,884
+138
| +0.1% | +$2.77K | 0.05% | 322 |
|
|
2018
Q1 | $2.95M | Sell |
168,746
-35,520
| -17% | -$742K | 0.04% | 331 |
|
|
2017
Q4 | $4.7M | Sell |
204,266
-156,699
| -43% | -$3.25M | 0.06% | 227 |
|
|
2017
Q3 | $7.56M | Buy |
360,965
+43,779
| +14% | +$806K | 0.05% | 343 |
|
|
2017
Q2 | $6.4M | Buy |
317,186
+162,265
| +105% | +$3.54M | 0.04% | 432 |
|
|
2017
Q1 | $3.76M | Buy |
154,921
+16,640
| +12% | +$449K | 0.03% | 734 |
|
|
2016
Q4 | $3.72M | Sell |
138,281
-184
| -0.1% | -$4.54K | 0.03% | 725 |
|
|
2016
Q3 | $3.1M | Buy |
138,465
+124
| +0.1% | +$2.49K | 0.02% | 784 |
|
|
2016
Q2 | $2.95M | Buy |
138,341
+4,972
| +4% | +$93.7K | 0.02% | 778 |
|
|
2016
Q1 | $2.35M | Buy |
133,369
+3,763
| +3% | +$56.1K | 0.02% | 847 |
|
|
2015
Q4 | $1.95M | Buy |
129,606
+517
| +0.4% | +$7.95K | 0.02% | 904 |
|
|
2015
Q3 | $1.7M | Sell |
129,089
-1,718
| -1% | -$27.2K | 0.01% | 974 |
|
|
2015
Q2 | $2.46M | Sell |
130,807
-1,207
| -0.9% | -$25K | 0.02% | 882 |
|
|
2015
Q1 | $2.48M | Buy |
132,014
+4,498
| +4% | +$77.1K | 0.02% | 821 |
|
|
2014
Q4 | $2.12M | Buy |
127,516
+1,447
| +1% | +$30.5K | 0.01% | 954 |
|
|
2014
Q3 | $4.1M | Buy |
126,069
+2,168
| +2% | +$73.6K | 0.03% | 607 |
|
|
2014
Q2 | $4.33M | Buy |
123,901
+3,382
| +3% | +$111K | 0.03% | 611 |
|
|
2014
Q1 | $3.82M | Buy |
120,519
+2,287
| +2% | +$63.6K | 0.03% | 668 |
|
|
2013
Q4 | $2.99M | Sell |
118,232
-1,970
| -2% | -$47.1K | 0.02% | 766 |
|
|
2013
Q3 | $2.57M | Buy |
120,202
+2,336
| +2% | +$48K | 0.02% | 802 |
|
|
2013
Q2 | $2.28M | Buy |
+117,866
| New | +$2.57M | 0.02% | 814 |
|
Other funds holding PTEN
Metropolitan Life Insurance Company (MetLife)'s PTEN Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Patterson-UTI (PTEN) in Q2 2024, closing a stake of 18,592 shares — an estimated $222K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in PTEN in Q2 2013 and held it in 44 quarters. The position peaked at $7.56M in Q3 2017. 359 funds tracked by Wall St. Rank hold PTEN as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Patterson-UTI position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 18,592 Patterson-UTI shares in Q2 2024, an estimated $222K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Patterson-UTI in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Patterson-UTI position peaked at $7.56M in Q3 2017.
- 359 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.